Influence of Hypoxic Induced Factors in Patients With Hereditary Hemorrhagic Telangiectasia

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Essen

About this trial

Patients with hereditary hemorrhagic telangiectasia (HHT) suffer from an inherited disorder leading to systemic vascular malformations. Mutations in several genes of the transforming growth factor (TGF)-β superfamily pathway influence angiogenesis in patients with HHT. The genetic loss of ALK1 or ENG alone are not sufficient to induce AVMs; environmental insults that could trigger angiogenesis (e.g. wounding) are also needed. In this study it will be analyzed if hypoxic induced factors could have an influence on the disease HHT.

Eligibility criteria

Qualifiers

diagnosed HHT (genetic testing and/ or fulfill at least 3 Curacao Criteria)

older than 17 years

ability to consent

Disqualifiers

if inclusion Criteria are not met

Trial design

Treatments tested in this trial

  • hypoxic induced factors

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators